Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 🧪 [Virginia] Hard-to-detect synthetic opioids evade fentanyl test strips, toxicologist warns - wtop.com
- 🌿 [Dallas, TX] How is the Texas THC ban affecting users? Results are mixed, Dallas doctor says - dallasobserver.com
- 🍄 [Baltimore, MD] Sheppard Pratt study: Psilocybin may ease suicidal thoughts - baltimoresun.com
- 🌿 [National] Kratom and 7-OH should be regulated, experts agree. They’re split on how - statnews.com
- 🛰️ [National] How the Pentagon Is Escalating Trump’s Drug War in Latin America - wsj.com
🗣️ Social Pulse
Lived/Living Experience
- No posts found today.
Innovation
- 🧮 A framework to determine naloxone saturation with simulation modeling and cost-effectiveness methods (link) - @AddictionJrnl on X
- 🚑 An enforcement action can stop illegal activity. It can also abruptly cut patients off from opioids, MOUD or other medications and increase overdose risk. CDC has a program specifically designed for that problem. (link) - @ActionForOD on X
Opposition Views
- No posts found today.
🏙 City Updates
📚 Academic Research
- 💉 Deaths not in vain-- A retrospective analysis of New York City overdose mortality to inform future overdose prevention strategies that address polysubstance use and drug use along the life course - CUNY Academic Works (City University of New York) - 2026-09-30 - academicworks.cuny.edu
- 🧪 Drug Checking as Market Surveillance - 2026-09-28 - doi.org
- 🩺 Modifiable Factors Associated With Substance Use Disorder Screening by Nurses: A Cross‐Sectional Survey - Journal of Clinical Nursing - 2026-09-24 - doi.org
⚖️ Law & Policy
State Laws
💸 Funding
Current
- Deadline Approaching🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- Deadline Approaching🔬 National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- 🛠️ Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA) - Deadline: Nov 2, 2026
- 🔬 National Institutes of Health - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) - Deadline: Jun 16, 2028
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🩺 Hearst Foundations - Health - Hearst Foundations – Health (year-round, rolling application) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 🗓️ Hearst Foundations - Social Service - Hearst Foundations—Social Service (Year-round rolling applications) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 🤝 Smart Family Fund - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch